Attention A T users. To access the menus on this page please perform the following steps. 1. Please switch auto forms mode to off. 2. Hit enter to expand a main menu option (Health, Benefits, etc). 3. To enter and activate the submenu links, hit the down arrow. You will now be able to tab or arrow up or down through the submenu options to access/activate the submenu links.

Center for Health Equity Research and Promotion

Menu
Menu

Quick Links

Veterans Crisis Line Badge
My healthevet badge
EBenefits Badge
 

Walid F. Gellad, MD, MPH

 

CHERP Core Investigator
Staff Physician, VA Pittsburgh Healthcare System
Associate Professor of Medicine, University of Pittsburgh School of Medicine
Associate Professor of Health Policy and Management, University of Pittsburgh Graduate School of Public Health
Co-Director, Center for Pharmceutical Policy and Prescribing

 

Research Interests:

 Dr. Gellad's research focuses on physician prescribing practices and on policy issues affecting access and adherence to medications for patients. He was the recipient of a career development award from the Department of Veterans Affairs to study the quality and efficiency of prescribing in the VA and is currently funded by the VA, NIH, CDC, and the state of Pennsylvania on multiple studies of pharmaceutical policy and prescription use. His work spans clinical areas, from diabetes, to hepatitis c, to prescription drug and substance abuse. His policy area of expertise is prescription drug pricing and spending. He is a former member of the Food and Drug Administration (FDA) advisory committee on nonprescription drugs and currently an alternate member of the FDA Drug Safety Oversight Board.

Dr. Gellad is also a nationally recognized authority on improving the measurement of medication adherence. In 2015, he founded and chaired the first national conference focused on improving the science behind medication adherence measurement.

Dr. Gellad is board certified in internal medicine and completed a residency and chief residency in internal medicine at Brigham and Women's Hospital and Harvard Medical School. He sees primary care patients in the VA Pittsburgh Heathcare System and attends on the inpatient general medical service.

 

New of note:  Dr. Gellad's work comparing outcomes for Veterans who are covered by both VHA and Medicare Part D shows significantly higher risk for death from prescription opioids. 

 https://www.usnews.com/news/health-news/articles/2019-03-11/vets-who-get-opioids-from-va-medicare-at-higher-overdose-risk

Current VA-Funded Research:

STORM Implementation Program Evaluation (SDR 16-193), Principal Investigator

Safety of Opioid Use Among Veterans Receiving Care in Multiple Health Systems (IIR 14-297), Principal Investigator

 

 Read profile of Dr. Gellad in Genetic Engineering & Biotechnology News

Read more about Dr. Gellad's Career Development Award.

 Read about Dr. Gellad's publication with Secretary Shulkin in the Journal of General Internal Medicine

walid.gellad@va.gov

Twitter:  @walidgellad